GLP-1 Drugs in Perioperative Care: How to Manage Them Around Surgery
Review of GLP-1 drug use in perioperative settings covers preoperative management, anesthesia considerations, aspiration risk, and postoperative glycemic control.
Quick Facts
What This Study Found
Review of GLP-1 drug use in perioperative settings covers preoperative management, anesthesia considerations, aspiration risk, and postoperative glycemic control.
Key Numbers
Single patient case; specific gastric volume not detailed in abstract.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Review of GLP-1 drug use in perioperative settings covers preoperative management, anesthesia consid
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- The Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Perioperative Period: A Case Study.
- Published In:
- Cureus, 17(1), e77106 (2025)
- Database ID:
- RPEP-09942
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Review of GLP-1 drug use in perioperative settings covers preoperative management, anesthesia considerations, aspiration risk, and postoperative glycemic control.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09942APA
Anderson, Todd R; Bushhouse, Mark; Carletto, Emily J; Holder, Kelly. (2025). The Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Perioperative Period: A Case Study.. Cureus, 17(1), e77106. https://doi.org/10.7759/cureus.77106
MLA
Anderson, Todd R, et al. "The Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Perioperative Period: A Case Study.." Cureus, 2025. https://doi.org/10.7759/cureus.77106
RethinkPeptides
RethinkPeptides Research Database. "The Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in the P..." RPEP-09942. Retrieved from https://rethinkpeptides.com/research/anderson-2025-the-use-of-glucagonlike
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.